Novartis
NVS
#61
Rank
$190.27 B
Marketcap
$93.08
Share price
-0.13%
Change (1 day)
-4.99%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Cash on Hand

Cash on Hand as of December 2023 : $13.96 B

According to Novartis's latest financial reports the company has $13.96 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novartis - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$13.96 B-25%
2022-12-31$18.61 B-33.79%
2021-12-31$28.11 B148.94%
2020-12-31$11.29 B0.53%
2019-12-31$11.23 B-29.63%
2018-12-31$15.96 B68.31%
2017-12-31$9.48 B21.96%
2016-12-31$7.77 B42.78%
2015-12-31$5.44 B-60.71%
2014-12-31$13.86 B50.31%
2013-12-31$9.22 B13.59%
2012-12-31$8.11 B59.98%
2011-12-31$5.07 B-37.61%
2010-12-31$8.13 B-53.38%
2009-12-31$17.44 B185.25%
2008-12-31$6.11 B-53.66%
2007-12-31$13.20 B65.95%
2006-12-31$7.95 B-27.24%
2005-12-31$10.93 B-21.3%
2004-12-31$13.89 B4.77%
2003-12-31$13.25 B5.72%
2002-12-31$12.54 B-4.86%
2001-12-31$13.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$22.92 B 64.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.69 B-9.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.27 B-47.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.92 B-28.89%๐Ÿ‡ซ๐Ÿ‡ท France
$7.09 B-49.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.28 B-12.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.86 B-58.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.35 B-54.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.22 B-76.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel